1 |
pharmacokinetic-pharmacodynamic
(770 times)
|
Pharmacology (317 times)
|
PK (53 times) AUC (27 times) MIC (25 times)
|
1990 Simultaneous modeling of the pharmacokinetic and pharmacodynamic properties of benzodiazepines. I: Lorazepam.
|
2 |
PK-pharmacodynamic
(8 times)
|
Pharmacology (4 times)
|
PK (8 times) BIS (2 times) ACR (1 time)
|
2008 Population approaches in paediatrics.
|
3 |
pharmacodynamic-pharmacokinetic
(2 times)
|
Drug Therapy (1 time)
|
ARC (1 time) CHD (1 time) CLCR (1 time)
|
2018 Research on the mechanism of drug-drug interaction between salvianolate injection and aspirin based on the metabolic enzyme and PK-PD model: study protocol for a PK-PD trial.
|
4 |
pharmacokinetic-PD
(2 times)
|
Drug Therapy (1 time)
|
PD (2 times) CI (1 time) EEG (1 time)
|
2011 Predicting brain occupancy from plasma levels using PET: superiority of combining pharmacokinetics with pharmacodynamics while modeling the relationship.
|
5 |
population pharmacokinetic and pharmacodynamic
(2 times)
|
Pharmacology (1 time)
|
ASNase (1 time) IMPDH (1 time) MPA (1 time)
|
2007 Clinical pharmacology of asparaginases in the United States: asparaginase population pharmacokinetic and pharmacodynamic (PK-PD) models (NONMEM) in adult and pediatric ALL patients.
|
6 |
pharmacokinetic and PD
(1 time)
|
Drug Therapy (1 time)
|
PD (1 time) PTA (1 time) SDD (1 time)
|
2020 A Pharmacokinetic-Pharmacodynamic Analysis to Dose Optimize Daptomycin in Vancomycin-Resistant Enterococcus faecium: Is the Answer Fixed Dosing or Lowering Breakpoints?
|
7 |
pharmacokinetic-pharmacodynamic integration
(1 time)
|
Pharmacology (1 time)
|
---
|
2012 From basic to clinical neuropharmacology: targetophilia or pharmacodynamics?
|
8 |
pharmacokinetic-pharmacodynamic modeling
(1 time)
|
Pharmacology (1 time)
|
Rtot (1 time)
|
1997 Pharmacokinetic-pharmacodynamic modeling of doxacurium: effect of input rate.
|
9 |
pharmacokinetic-pharmacodynamic relationship
(1 time)
|
Pharmacological Phenomena (1 time)
|
nano-MSCs (1 time) NPs (1 time) PD (1 time)
|
2021 Pharmacokinetic-Pharmacodynamic Modeling of Tumor Targeted Drug Delivery Using Nano-Engineered Mesenchymal Stem Cells.
|